Novartis's Afinitor receives first approval in US for kidney cancer
31 March 2009
Malini Guha
Novartis's Afinitor (everolimus) has received its first worldwide approval for the treatment of advanced renal cell carcinoma (kidney cancer) in the US, for patients who have progressed on treatment with other targeted anticancer drugs approved for the disease.
The mTOR-targeted drug will be available...
Please Login to read the full article.
31 March 2009
Malini Guha
The mTOR-targeted drug will be available...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
